Case number 2020-1213
Galderma Laboratories, L.P. v. Teva Pharmaceuticals USA, Inc > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 6, 2020 | 6 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [676914] [19-2396, 20-1213] [JAB] [Entered: 03/06/2020 11:25 AM] (1) |
| Jan 29, 2020 | 4 | OPINION filed for the court by Moore, Circuit Judge; O'Malley, Circuit Judge and Stoll, Circuit Judge. Nonprecedential Opinion. [666760] [19-2396, 20-1213] [JAB] [Entered: 01/29/2020 09:33 AM] (17) |
| Jan 29, 2020 | 5 | JUDGMENT. REVERSED AND REMANDED AS TO CASE NO. 2019-2396; DISMISSED AS TO CASE NO. 2020-1213. Terminated on the merits after submission on the briefs. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [666764] [19-2396, 20-1213] [JAB] [Entered: 01/29/2020 09:34 AM] (2) |
| Dec 6, 2019 | 1 | Appeal docketed. Received: 11/27/2019. [654505]. [TAM] [Entered: 12/06/2019 10:14 AM] (33) |
| Dec 6, 2019 | 2 | Note to file: The following cases are associated:19-2396 (Lead) with 20-1213 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [654523] [19-2396, 20-1213] [TAM] [Entered: 12/06/2019 10:22 AM] (0) |
| Dec 6, 2019 | 3 | ORDER directing Teva to inform this court by Monday, December 9, 2019 at 3:00 pm whether it intends to brief the injunction issue. (see order for details) Service as of this date by the Clerk of Court. [654546] [19-2396, 20-1213] [LMS] [Entered: 12/06/2019 10:57 AM] (2) |
